0.4481
price up icon1.79%   0.0079
after-market Handel nachbörslich: .43 -0.0181 -4.04%
loading
Schlusskurs vom Vortag:
$0.4402
Offen:
$0.4295
24-Stunden-Volumen:
982.04K
Relative Volume:
0.66
Marktkapitalisierung:
$183.87M
Einnahmen:
$306.91M
Nettoeinkommen (Verlust:
$-59.11M
KGV:
-2.9873
EPS:
-0.15
Netto-Cashflow:
$6.35M
1W Leistung:
-3.53%
1M Leistung:
-17.31%
6M Leistung:
-28.52%
1J Leistung:
-49.70%
1-Tages-Spanne:
Value
$0.4295
$0.4516
1-Wochen-Bereich:
Value
$0.4246
$0.4795
52-Wochen-Spanne:
Value
$0.354
$1.11

Amarin Corp Adr Stock (AMRN) Company Profile

Name
Firmenname
Amarin Corp Adr
Name
Telefon
353 1 6699 020
Name
Adresse
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
Name
Mitarbeiter
275
Name
Twitter
@amarincorp
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
AMRN's Discussions on Twitter

Vergleichen Sie AMRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
AMRN
Amarin Corp Adr
0.4481 183.87M 306.91M -59.11M 6.35M -0.15
Drug Manufacturers - General icon
LLY
Lilly Eli Co
825.91 739.17B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
209.52 370.74B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
165.84 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.44 311.44B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
MRK
Merck Co Inc
89.76 226.76B 64.17B 17.12B 18.10B 6.73

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-20 Fortgesetzt JP Morgan Underweight
2023-10-25 Herabstufung Jefferies Buy → Hold
2023-01-06 Hochstufung Jefferies Hold → Buy
2022-05-06 Herabstufung JP Morgan Neutral → Underweight
2022-05-05 Herabstufung H.C. Wainwright Buy → Neutral
2022-05-05 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-05-04 Herabstufung Northland Capital Outperform → Market Perform
2021-05-12 Herabstufung Goldman Neutral → Sell
2020-09-29 Fortgesetzt JP Morgan Neutral
2020-08-26 Eingeleitet Piper Sandler Overweight
2020-05-05 Eingeleitet Northland Capital Outperform
2020-03-31 Herabstufung Goldman Buy → Neutral
2020-03-31 Herabstufung Jefferies Buy → Hold
2020-03-31 Hochstufung Oppenheimer Underperform → Perform
2020-03-13 Hochstufung Goldman Neutral → Buy
2020-03-02 Eingeleitet Cowen Outperform
2020-02-18 Hochstufung Citigroup Neutral → Buy
2020-01-06 Eingeleitet JP Morgan Neutral
2019-12-16 Herabstufung Stifel Buy → Hold
2019-11-20 Eingeleitet Oppenheimer Underperform
2019-11-18 Herabstufung Citigroup Buy → Neutral
2019-11-15 Bestätigt SVB Leerink Outperform
2019-10-31 Eingeleitet Aegis Capital Buy
2019-10-15 Eingeleitet Goldman Neutral
2019-08-14 Eingeleitet SVB Leerink Outperform
2019-07-09 Bestätigt Jefferies Buy
2019-06-17 Eingeleitet ROTH Capital Buy
2019-03-22 Eingeleitet Stifel Buy
Alle ansehen

Amarin Corp Adr Aktie (AMRN) Neueste Nachrichten

pulisher
Mar 18, 2025

Assessing the Risk and Potential of Sempra’s (SRE) Stock - The News Heater

Mar 18, 2025
pulisher
Mar 13, 2025

Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 13, 2025
pulisher
Mar 13, 2025

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript - The Motley Fool

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin announce splan to initiate ratio change under ADR program - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Corp. (AMRN) Announces 1-For-20 ADS Ratio Change to Maintain Nasdaq Listing - StreetInsider.com

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - StockTitan

Mar 12, 2025
pulisher
Feb 25, 2025

How Amarin's Latest European Reimbursement Victory Strengthens Its Cardiovascular Market Position - Stock Titan

Feb 25, 2025
pulisher
Feb 19, 2025

Will Amarin's Q4 Earnings Mark a Turning Point? Key Date and Details Revealed - Stock Titan

Feb 19, 2025
pulisher
Feb 13, 2025

Amarin Corp ADR (AMRN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Feb 13, 2025
pulisher
Feb 12, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView

Feb 12, 2025
pulisher
Feb 10, 2025

Amarin Corp ADR [AMRN] Stock bought by Insider Berg Aaron for $0.1 million - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Ratios Uncovered: Breaking Down Amarin Corp ADR (AMRN)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Checking in on Indivior Plc (INDV) after recent insiders movement - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 10, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Amarin Corp ADR (AMRN) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Views of Wall Street’s Leading Experts on SciSparc Ltd - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Stocks of Talen Energy Corp (TLN) are poised to climb above their peers - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Amarin Corp ADR (AMRN) shows promising results - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Analysts review Amarin Corp ADR’s rating - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

ALLY’s latest rating updates from top analysts. - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Ratio Review: Analyzing Caleres Inc (CAL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Health Report: Tevogen Bio Holdings Inc (TVGN)’s Ratios Tell a Tale - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Metrics Exploration: Understanding Opendoor Technologies Inc (OPEN) Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Potential Price Increase for Godaddy Inc (GDDY) After Recent Insider Activity - Knox Daily

Feb 04, 2025
pulisher
Jan 24, 2025

Analyzing Ratios: Amarin Corp ADR (AMRN)’s Financial Story Unveiled - The Dwinnex

Jan 24, 2025
pulisher
Jan 21, 2025

Establishment Labs Holdings Inc (ESTA) expanding its growth trajectory ahead - SETE News

Jan 21, 2025
pulisher
Jan 03, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN

Jan 03, 2025
pulisher
Dec 19, 2024

Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com

Dec 19, 2024
pulisher
Dec 16, 2024

Italy grants VAZKEPA reimbursement for heart risk - Investing.com

Dec 16, 2024
pulisher
Dec 14, 2024

Amarin Corporation plc (ADR) : Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) - Marketscreener.com

Dec 14, 2024
pulisher
Dec 13, 2024

Amarin appoints new chief financial officer - Investing.com

Dec 13, 2024
pulisher
Dec 13, 2024

Amarin Appoints Peter Fishman Chief Financial Officer - GlobeNewswire Inc.

Dec 13, 2024
pulisher
Dec 11, 2024

Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com

Dec 11, 2024
pulisher
Nov 24, 2024

Amarin granted extension to meet Nasdaq listing standards - Investing.com

Nov 24, 2024
pulisher
Nov 21, 2024

European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN

Nov 21, 2024
pulisher
Nov 20, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga

Nov 19, 2024
pulisher
Nov 11, 2024

Amarin stock touches 52-week low at $0.55 amid market challenges - Investing.com

Nov 11, 2024
pulisher
Nov 10, 2024

European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN

Nov 10, 2024
pulisher
Nov 06, 2024

A Must-See Look at Amarin's Best- and Worst-Case Scenarios - AOL

Nov 06, 2024
pulisher
Oct 31, 2024

Amarin's Q3 Earnings In Line, Revenues Fall Shy Of Estimates - Barchart

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Amarin reports Q3 revenue dip amid U.S. generic competition - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript - AOL

Oct 31, 2024
pulisher
Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Amarin stock plunges to 52-week low of $0.56 amid market challenges - Investing.com India

Oct 24, 2024
pulisher
Oct 18, 2024

European Equities Traded in the US as American Depositary Receipts Decline Tuesday - MSN

Oct 18, 2024

Finanzdaten der Amarin Corp Adr-Aktie (AMRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$55.46
price down icon 0.64%
$112.05
price up icon 0.23%
drug_manufacturers_general PFE
$25.34
price up icon 0.52%
$311.55
price up icon 1.50%
drug_manufacturers_general NVS
$111.48
price down icon 0.97%
drug_manufacturers_general MRK
$89.76
price up icon 0.59%
Kapitalisierung:     |  Volumen (24h):